Atlas Trials

Phase 2

89,854 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 2

RecordFirmDate
The Effect of GCSF in the Treatment of ALS Patients (NCT01825551)Tehran University of Medical Sciences2012-11-01
Allogeneic Stem Cells Implantation Combined With Coronary Bypass Grafting in Patients With Ischemic Cardiomyopathy (NCT01753440)AHEPA University Hospital2012-11-01
Exercise and Vascular Function in Haemodialysis Patients (NCT01591876)Queen Margaret University2012-11-01
Intrabone Transplantation of Allogenic Peripheral Blood Stem Cells in Patients With Myeloid and Lymphoid Malignancies. (NCT01728389)Maria Sklodowska-Curie National Research Institute of Oncology2012-11-01
Determination of Biological Activity of Three Allergen Extracts (NCT02474836)Roxall Medicina España S.A2012-11-01
Metformin and 5-fluorouracil for Refractory Colorectal Cancer. (NCT01941953)Instituto do Cancer do Estado de São Paulo2012-11-01
Decitabine Combining Modified CAG Followed by HLA Haploidentical Peripheral Blood Mononuclear Cells Infusion for Elderly Patients With Acute Myeloid Leukemia(AML) (NCT01690507)Chinese PLA General Hospital2012-11-01
A Study Comparing the Safety and Effectiveness of Cartilage Cell Injected Into the Lumbar Disc as Compared to a Placebo (NCT01771471)ISTO Technologies, Inc.2012-11-01
Immediate Effects of Dry Needling and Tens in Chronic Neck Pain (NCT02230709)Universidad Rey Juan Carlos2012-11-01
A Phase I/II Trial of VB-111 and Paclitaxel for Recurrent Platinum-Resistant Müllerian Cancer (NCT01711970)Vascular Biogenics Ltd. operating as VBL Therapeutics2012-11-01
The Effects of RVX000222 on Glucose Metabolism in Individuals With Pre-diabetes (NCT01728467)Resverlogix Corp2012-11-01
Effect of Local Anesthesia in Patients With Marginal Periodontitis Undergoing Scaling and Root Planning (NCT01878864)Ove Andersen2012-11-01
Pilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patients (NCT01687751)Fraser Health2012-11-01
Dose-finding Study of Abraxane in Combination With Cisplatin to Treat Advanced Nasopharyngeal Carcinoma (NCT01735409)Sun Yat-sen University2012-11-01
Miravirsen Study in Null Responder to Pegylated Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C (NCT01727934)Santaris Pharma A/S2012-11-01
Chlorhexidine Skin Application for Prevention of Infection in Infants Weighing <1500 g at Birth (NCT01723501)All India Institute of Medical Sciences2012-11-01
A Study, Performed in Subjects With Post Traumatic-post Surgical ,Venus Insufficiency and Diabetic Hard to Heal/Chronic Wounds, to Evaluate the Safety and Efficacy of PolyHeal-2 Versus PolyHeal in Once Daily Regimen (NCT01679678)MediWound Ltd2012-11-01
A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria (NCT01756703)Tanabe Pharma Corporation2012-11-01
High "on Treatment" Platelet Reactivity in the Intensive Care Unit (NCT02285751)Medical University of Vienna2012-11-01
Evaluation of the Efficacy and Tolerability of Treatment With Interleukin-2 in Severe and Resistant Alopecia Areata (NCT01840046)Centre Hospitalier Universitaire de Nice2012-11-01
Phase 2 Study in Japanese Patients With Intermediate-2 or High Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis With Splenomegaly (NCT01692366)Bristol-Myers Squibb2012-11-01
Cisplatinum/Pemetrexed Versus Split-dose Cisplatinum/Pemetrexed In NSCLC (NCT01742767)Universität Duisburg-Essen2012-11-01
Intrabone Infusion of Umbilical Cord Blood Stem Cells (NCT01711788)Henrique Bittencourt, MD, PhD2012-11-01
Erlotinib With Concurrent Brain Radiotherapy and Secondary Brain Radiotherapy After Recurrence With Erlotinib in NSCLC Non-increased-intracranial-pressure Symptomatic Brain Metastases (NCT01763385)Wu Jieping Medical Foundation2012-11-01
The Effect of Treatment With Teriparatide and Zoledronic Acid in Patients With Osteogenesis Imperfecta (NCT01679080)University of Aarhus2012-11-01
A Phase 1/2b Study of an Investigational Malaria Vaccination Strategy in 5-17 Month Old Infants and Children in Burkina Faso (NCT01635647)University of Oxford2012-11-01
Inflammation Inhibition in Prediabetic Humans (NCT01977417)Gary L. Pierce2012-11-01
Safety and Efficacy of MT-4666 (NCT01764243)Tanabe Pharma Corporation2012-11-01
Trastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on Trastuzumab (NCT01479179)M.D. Anderson Cancer Center2012-11-01
Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC (NCT01733589)Zhejiang Cancer Hospital2012-11-01
Bringing What Works to Youth in Corrections: A Trauma Intervention (NCT01560728)University of Texas at Austin2012-11-01
Dose-finding Study in Platinum-Resistant Ovarian Cancer (NCT01653912)Accenture2012-11-01
Phase II Study With Hiltonol and Dendritic Cells in Solid Tumors (NCT01734564)Clinica Universidad de Navarra, Universidad de Navarra2012-11-01
Safety and Efficacy of IM Injections of PLX-PAD for the Regeneration of Injured Gluteal Musculature After Total Hip Arthroplasty (NCT01525667)Pluristem Ltd.2012-11-01
Pilot Study to Evaluate the Impact of Denosumab on Disseminated Tumor Cells (DTC) in Patients With Early Stage Breast Cancer (NCT01545648)Hope Rugo, MD2012-11-01
The Effect of Intraoperative Labetalol on Time to Discharge (NCT02997800)Dr. Robert Tanzola2012-11-01
Kudzu Effects on Brain Ethanol Levels: Proton Spectroscopy Assessment (NCT01739842)Mclean Hospital2012-11-01
Intracavitary Cisplatin-Fibrin Localized Chemotherapy After P/D or EPP for Malignant Pleural Mesothelioma (NCT01644994)University of Zurich2012-11-01
Mechanisms of Improved Wound Healing and Protein Synthesis of Insulin and Metformin (NCT01666665)The University of Texas Medical Branch, Galveston2012-11-01
The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer (NCT01739634)Salient Pharmaceuticals Incorporated2012-11-01
Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer (NCT01727089)National Cancer Institute (NCI)2012-11-01
Nitrous Oxide as Treatment for Major Depression - a Pilot Study (NCT02139540)Washington University School of Medicine2012-11-01
Statin Therapy in Young Adult Survivors of Childhood Cancer (NCT01733953)University of Minnesota2012-11-01
To Study the Safety and Efficacy of Autologous Bone Marrow Stem Cells in Patients With Spinal Cord Injury (NCT01730183)Max Institute of Neurosciences2012-11-01
Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease (NCT01735630)OPKO Health, Inc.2012-11-01
Atomoxetine Treatment for Cognitive Impairment in Parkinson's Disease (ATM-Cog) (NCT01738191)Medical University of South Carolina2012-11-01
Dasatinib for Patients Achieving Complete Molecular Response for Cure D-NewS Trial (NCT01887561)Kanto CML Study Group2012-11-01
A Biomarker Study in Patients With HER2-negative Metastatic Breast Cancer Treated With Bevacizumab and Paclitaxel (NCT01722968)Theodoros Foukakis2012-11-01
Lung Bioavailability and Total Systemic Exposure to Beclomethasone17MonoPropionate and Formoterol Across Two Strengths of NEXThaler Inhalation Powder (NCT01738087)Chiesi Farmaceutici S.p.A.2012-11-01
Biological Standardization of Chenopodium Album Allergen Extract (NCT01675349)Laboratorios Leti, S.L.2012-11-01
Ranolazine Cardioprotection in PCI (NCT01767987)Harvey Hahn2012-11-01
tDCS to Enhance Cognitive Training in Schizophrenia (NCT01733602)The University of New South Wales2012-11-01
Ipilimumab With Carboplatin and Paclitaxel in Patients With Unresectable Stage III and Stage IV Melanoma (NCT01676649)Jewish General Hospital2012-11-01
Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil (NCT01712074)Pfizer2012-11-01
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis (NCT01772823)University of North Carolina, Chapel Hill2012-11-01
Doxycycline, Temozolomide and Ipilimumab in Melanoma (NCT01590082)M.D. Anderson Cancer Center2012-11-01
Effects of Ibudilast on Oxycodone Self-administration in Opioid Abusers (NCT01740414)New York State Psychiatric Institute2012-11-01
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for Treatment of Common Warts (NCT01286441)ViroXis Corporation2012-11-01
A Booster Dose of Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children (NCT01734408)Jiangsu Province Centers for Disease Control and Prevention2012-11-01
A Dose Response Evaluation of SLITone Ultra HDM Mix Immunotherapy (NCT01728298)ALK-Abelló A/S2012-11-01
Efficacy and Safety of Kochujang Pills on Improvement of Blood Lipids (NCT01735149)Chonbuk National University Hospital2012-11-01
Effect of Taurine on Glycemic Control in Type I and Type II Diabetic Patients (NCT01226537)Hamad Medical Corporation2012-11-01
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) (NCT01722318)Bausch Health Americas, Inc.2012-11-01
Effects of Inspiratory Muscle Training After Lung Cancer Surgery, a Randomized Controlled Trial (NCT01793155)Aalborg University Hospital2012-11-01
A Phase I-II Study of HM781-36B Combined With Paclitaxel and Trastuzumab in HER-2 Positive Advanced Gastric Cancer (NCT01746771)Hanmi Pharmaceutical Company Limited2012-11-01
CYT003-QbG10, a TLR9-agonist, for Treatment of Uncontrolled Moderate to Severe Allergic Asthma (NCT01673672)Cytos Biotechnology AG2012-11-01
Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD) (NCT01678963)Ohr Pharmaceutical Inc.2012-11-01
Efficacy and Safety of GRT6005 in Patients With Chronic Low Back Pain. (NCT01725087)Tris Pharma, Inc.2012-11-01
Phase 2 Study of TD-9855 to Treat Fibromyalgia (NCT01693692)Theravance Biopharma2012-11-01
A Phase I-II Study of PAXG in Stage III-IV Pancreatic Adenocarcinoma (NCT01730222)IRCCS San Raffaele2012-11-01
Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal Cancer (NCT01650350)Brown University2012-11-01
Safety and Efficacy of Sofosbuvir and Ribavirin in Adults With Recurrent Chronic Hepatitis C Virus (HCV) Post Liver Transplant (NCT01687270)Gilead Sciences2012-11-01
Acetyl Hexapeptide-8 for Blepharospasm (NCT01750346)National Institute of Neurological Disorders and Stroke (NINDS)2012-11-01
MTD Determination, Safety and Efficacy of the Decitabine-Genistein Drug Combination in Advanced Solid Tumors and Non-Small Cell Lung Cancer (NCT01628471)Uman Pharma2012-11-01
Cetuximab for Elderly Patients With mCRC (NCT01718808)Swiss Cancer Institute2012-11-01
Pharmacokinetic, Efficacy and Safety Study of Tapentadol Oral Solution in Children With Postoperative Pain (NCT01729728)Grünenthal GmbH2012-11-01
A Phase II Study of Dovitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands (NCT01678105)Ontario Clinical Oncology Group (OCOG)2012-11-01
Trial of Curcumin in Cutaneous T-cell Lymphoma Patients (NCT00969085)M.D. Anderson Cancer Center2012-11-01
Study of Individualized Therapies Selection for Patients With Metastatic Colorectal Carcinoma According to the Therapeutic (NCT01703910)Centro Nacional de Investigaciones Oncologicas CARLOS III2012-11-01
Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast Cancer (NCT01928680)Chinese Academy of Medical Sciences2012-11-01
Pilot Study to Evaluate SYL1001 Safety and Effect in Patients With Ocular Pain (NCT01776658)Sylentis, S.A.2012-11-01
Efficacy and Safety of QMF149 vs. Salmeterol Xinafoate/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT01636076)Novartis Pharmaceuticals2012-11-01
DIetary Supplements, Executive funcTions and Vitamin D (DIET-D) (NCT01708005)University Hospital, Angers2012-11-01
T-705a Multicenter Study in Adults Subjects With Uncomplicated Influenza (NCT01728753)MDVI, LLC2012-11-01
Pilot Study of Tocilizumab in Patients With Erdheim-Chester Disease (NCT01727206)Ospedale San Raffaele2012-11-01
Low-dose Propofol for Pediatric Migraine (NCT01604785)Oregon Health and Science University2012-11-01
Treatment of Gastric Peritoneal Carcinomatosis by Association of Complete Surgical Resection of the Lesions and Intraperitoneal Immunotherapy Using Catumaxomab (NCT01784900)Gustave Roussy, Cancer Campus, Grand Paris2012-11-01
Evaluation of an School-based Alcohol Prevention Program for Middle School Students (NCT01847183)Oregon Research Institute2012-11-01
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH) (NCT01725256)Aires Pharmaceuticals, Inc.2012-11-01
Evaluation of Ultrafast Hypothermia Before Reperfusion in STEMI Patients (NCT01655433)Velomedix, Inc.2012-11-01
Intra-monocyte Imiglucerase Kinetics in Gaucher Disease (NCT01951989)University Hospital, Clermont-Ferrand2012-11-01
Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status (NCT01690598)Vejle Hospital2012-11-01
Examination of the Bronchoprotective Effect of Endothelin Receptor Blockade in Asthma (NCT01617746)University of Glasgow2012-11-01
Efficacy and Safety of Eltrombopag In Patients With Severe and Very Severe Aplastic Anemia (NCT01703169)University of Utah2012-11-01
Brain Monitoring, tDCS and Robotic Training in SCI (NCT06813287)Kathleen Friel2012-11-01
Tivozanib in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Triple Negative Breast Cancer (NCT01745367)AVEO Pharmaceuticals, Inc.2012-11-01
Evaluate the Safety and Tolerability of Vandetanib in Japanese Patients With Medullary Thyroid Carcinoma (NCT01661179)Genzyme, a Sanofi Company2012-11-01
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD) (NCT01724112)BlackThorn Therapeutics, Inc.2012-11-01
A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Trastuzumab Emtansine (T-DM1) With or Without Standard Endocrine Therapy vs. Trastuzumab With Standard Endocrine Therapy Given for Twelve Weeks in Patients With Operable HER2+/HR+ Breast Cancer Within the ADAPT Protocol. (NCT01745965)Women's Cancer Study Group GmbH2012-11-01
BEZ235 Phase II Trial in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET) After Failure of mTOR Inhibitor Therapy. (NCT01658436)Novartis Pharmaceuticals2012-11-01
← Previous Next →

Track Phase 2 automatically

Every clearance here is in the API, with alerts when new ones post.